Turning Point Benefit Group’s Boston Scientific BSX Stock Holding History

Turning Point Benefit Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,393	Closed	-$228K	–	193
2025 Q4	$228K	Sell	2,393 -1,004	-30%	-$98.4K	0.12%	81
2025 Q3	$326K	Sell	3,397 -424	-11%	-$43.9K	0.2%	69
2025 Q2	$410K	Buy	3,821 +215	+6%	+$21.8K	0.31%	55
2025 Q1	$330K	Buy	3,606 +345	+11%	+$34.7K	0.31%	54
2024 Q4	$309K	Buy	+3,261	New	+$287K	0.29%	48

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Turning Point Benefit Group's BSX Position: Q1 2026 in Review

Turning Point Benefit Group sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,393 shares — an estimated $228K sold.

Turning Point Benefit Group first reported a position in BSX in Q4 2024 and held it in 5 quarters. The position peaked at $410K in Q2 2025. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Turning Point Benefit Group reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Turning Point Benefit Group sold 2,393 Boston Scientific shares in Q1 2026, an estimated $228K.
Turning Point Benefit Group first reported a position in Boston Scientific in Q4 2024 and held it in 5 quarters.
Turning Point Benefit Group's Boston Scientific position peaked at $410K in Q2 2025.
1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Turning Point Benefit Group's 13F filing for Q1 2026, filed 12 May 2026.